Figure 1From: Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective studyKaplan-Meyer curve of time to resolution of neurological toxicity in patients with epithelial ovarian carcinoma treated with the combination of carboplatin and paclitaxel (dotted lines represent 95% confidence interval).Back to article page